Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

38.80
BATS BZX Real-Time Price
As of 12:17pm ET
 -0.09 / -0.23%
Today’s Change
37.20
Today|||52-Week Range
45.58
+0.75%
Year-to-Date
Flood of News Presents Buying Opportunity
Jan 17 / GuruFocus News - Paid Partner Content
3 Big Reasons (and 8 Smaller Ones) to Buy Ionis Pharmaceuticals Stock
Jan 10 / MotleyFool.com - Paid Partner Content
Is GlaxoSmithKline's Stock a Bargain After Dropping 4.8% in 2016?
Jan 13 / MotleyFool.com - Paid Partner Content
Bristol-Myers, GeneCentric Tie Up for Opdivo Biomarker Study
Jan 09 / Zacks.com - Paid Partner Content
4 Signs Glaxo's Turnaround Is Taking Hold
Jan 13 / MotleyFool.com - Paid Partner Content
Bristol-Myers, J&J Ink Immunotherapy Research Collaboration
Jan 06 / Zacks.com - Paid Partner Content
Merck: Keytruda+Chemo Gets Priority Review for Lung Cancer
Jan 11 / Zacks.com - Paid Partner Content
The Best Thing About Glaxo's Next Vaccine (Hint: It's Not the Billion-Dollar Sales Es...
Jan 06 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close38.89
Today’s open38.95
Day’s range38.73 - 39.07
Volume119,076
Average volume (3 months)3,636,314
Market cap$95.5B
Dividend yield5.38%
Data as of 12:17pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+11.00%
Earnings growth (next 5 years)+13.26%
Revenue growth (last year)-3.66%
P/E ratio346.7
Price/Sales2.70
Price/Book12.49

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.44-0.78%
ABBVAbbVie-0.23-0.37%
CELGCelgene-1.69-1.47%
SNYSanofi-0.52-1.28%
Data as of 12:19pm ET, 01/19/2017

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$0.57
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts


Search for Jobs